Shinva Medical Instrument Co., Ltd. (SHSE:600587) agreed to acquire 75% stake in Changchun Bioxun Biotech Co., Ltd. for approximately CNY 310 million from 49 individuals on July 20, 2012. The individuals are Dong Jianhua, Chen Weijia, Liu Haiqing, Chen Dazhi, Lu Qin, Xu Wenbin, Zhang Peng, Chu Rongmin, Du Bairong, Gaoming, Li Wang, Wang Guangyi, Wu Qiongyan, Li Zhigang, Yang Ming, Li Qiusheng, Chen Yinghan, Feng Fuxiang, Zhao Rong, Gu Guoxiang, Yang Hongcun, Liu Lihong, Wang Dongqian, Wang Zhe, Chen Wei, Jian Xiaoming, Feng Ligang, Zhang Tieqiang, Han Ming, Jia Tianbing, Zhao Yibo, Liu Ning, Zhu Jing, Li Lingbo, Zhang Shuai, Li Xijun, Yu Lu, Liu Jiaying, Nie Cuiping, Xu Guiqing, Wan Junbo, Guo Guangying, Gong Jianqiu, Xu Qiuju, Cao Shuyun, Yang Na, Liu Yu, Xu Hongli, and Jin Lijuan. The transaction will be funded by issuance of 14.46 million shares at CNY 22.51 to Shandong Energy Zi Bo Kuang Ye Group Co., Ltd., a Tianjin-based investment management center, and Dong Jianhua. The Board of Shinva Medical Instrument approved the transaction on July 20, 2012 and the shareholders of Shinva Medical Instrument will consider the transaction on August 6, 2012. Shandong Zhengyuan Hexin Assets Appraisal Limited appraised the assets of Changchun Bioxun Biotech Co., Ltd.